0623

Find out how CRISPR genome editing technologies are shaping the future of drug development; we ask experts about the hype versus reality. Also in this issue, patient centricity at Boehringer Ingelheim, real-world data, and why the pharma industry shouldn’t ignore the need for dengue treatments. Academics explain how they have converted plastic waste into pharmaceutical APIs, members of our Power List explore the challenges facing cell and gene therapy, and we invite you to learn more about the importance of crystallization for API manufacturing.

Register to download

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

I want to receive an alert when the next issue is available online

Articles featured in this issue

Discovery & Development Formulation

Superbugs Versus Supercomputers

05/17/2023 | Jamie Irvine | 2 min read

Developments in antivirulence drug treatments could solve the threat of antimicrobial resistance

Discovery & Development Drug Discovery

Nut a Problem

06/07/2023 | Jamie Irvine | 2 min read

Immunotherapy Viaskin Peanut shows promising results in desensitizing peanut-allergic toddlers.

Discovery & Development Clinical Trials

Putting Real-World Data to Work

03/09/2023 | Karen Ooms | 4 min read

How do we further integrate real-world data into clinical research and approval processes?

Business & Regulation Trends & Forecasts

Patient-Centric Perspectives

04/26/2023 | Keri Yale | 5 min read

Patient-centricity needs to be more than a buzzword. Here’s how Boehringer Ingelheim is weaving it into its culture.

Discovery & Development Drug Discovery

The Dangers of Dengue

06/13/2023 | Neelika Malavige | 4 min read

We need more investment for research into dengue treatments that can curb the overwhelming pressure placed on healthcare systems.

Discovery & Development Drug Delivery

Power List Perspectives: Challenges Facing Cell and Gene Therapy

05/12/2023 | Jamie Irvine

Leading pharma industry experts discuss the most pertinent challenges facing cell and gene therapy

Manufacture Biosimilars

The Imperfect Art of Biosimilars

05/25/2023 | Dave Li, Anna Baran | 5 min read

Need a refresher on biosimilars? Here, we offer some key points to keep in mind when it comes to structure, function, and interchangeability.

Discovery & Development Ingredients

From Plastic Pollution to Pharma Compounds

03/15/2023 | Stephanie Vine | 3 min read

How fungi help turn ocean trash into pharmaceutical platform molecules.

Manufacture Bioprocessing - Upstream & Downstream

mAbs: Not so Sweet

05/03/2023 | Neha Mishra, Jesus Zurdo | 9 min read

How fucosylation-deficient CHO cell hosts can help enhance the potency of monoclonal antibody-based biotherapeutics

Manufacture Small Molecules

The Dark Crystal

06/12/2023 | Andrew Blythe-Dickens | 7 min read

Though crystallization is considered a “black art” in some circles, it’s still a crucial part of the API manufacturing process

Other issues of 2023